Modeling combination Hepatitis C virus treatment and prevention strategies in a network of people who inject drugs in the United States
BACKGROUND: Hepatitis C virus (HCV) treatment as prevention (TasP) strategies can contribute to HCV microelimination, yet complimentary interventions such as opioid agonist therapies (OAT) with methadone or buprenorphine and syringe services programs (SSPs) may improve the prevention impact. This mo...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Published: |
Oxford University Press
2020
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/25880/ https://doi.org/10.1093/cid/ciaa142 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|